Event Details

Dr. Reddy's Laboratories Ltd. announced it has been invited to ring the Closing Bell® at the New York Stock Exchange (NYSE) on May 29, 2026, at 4:00 pm EDT (1:30 am IST on May 30, 2026). The ceremony will take place at the NYSE headquarters in New York City.

Purpose and Significance

The event commemorates the 25th anniversary of the company's listing on the NYSE. Dr. Reddy's became the first pharmaceutical company in Asia, outside Japan, to be listed on the NYSE in April 2001.

Participants

The senior management team attending the ceremony includes:

  • Satish Reddy, Chairman
  • Erez Israeli, Chief Executive Officer
  • M.V. Ramana, Chief Executive Officer-Global Generics
  • M.V. Narasimham, Chief Financial Officer
  • Milan Kalawadia, Chief Executive Officer-North America
  • K Randhir Singh, Head-Company Secretary & CSR
  • Arun M. Kumar, Independent Director
  • Penny Wan, Independent Director
  • Sridar Iyengar, former Independent Director
  • Other officials and invitees

Livestream Information

The Closing Bell® ceremony will be livestreamed on NYSE.com and the New York Stock Exchange YouTube channel.

Management Commentary

Chairman Satish Reddy stated: "Twenty-five years on the NYSE is more than a listing anniversary; it is a reaffirmation of our commitment to global governance, transparency, and innovation. When Dr. K. Anji Reddy founded this company, his vision was simple but powerful: bring affordable, innovative medicines to patients everywhere. That vision drove our NYSE debut in 2001 and continues to shape who we are today, a trusted name in the U.S. market, backed by differentiated products and consistent operations."

Company Background

Dr. Reddy's Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India, established in 1984. The company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC products. Major therapeutic areas of focus include gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Major markets include USA, India, Russia & CIS countries, China, Brazil and Europe.

Financial Impact

No financial impact or operational implications were disclosed in relation to this ceremonial event.

#Tags: #DrReddys #NYSE #ClosingBell #Regulation30 #Neutral